| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/18/2006 | WO2006051937A1 Five-membered heterocyclic derivatives |
| 05/18/2006 | WO2006020091A3 Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060104912 Mousse composition |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656943A1 Extract from plant of japanese parsley family and process for producing the same |
| 05/17/2006 | EP1656360A1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | CN1774254A Phosphate derivatives of pharmaceutical products |
| 05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045155 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes. |
| 05/16/2006 | CA2366856C Formulation comprising testosteron undecanoate and castor oil |
| 05/11/2006 | WO2006050402A1 Estrogen receptor modulators |
| 05/11/2006 | WO2006049889A1 Indole derivatives useful as progesterone receptor modulators |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048911A2 Pharmaceutical or nutraceutical compositions containing chromium or iron complexes of alpha-lipoic acid |
| 05/11/2006 | WO2006005759A3 Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586389A1 Modified growth hormones |
| 05/11/2006 | CA2585658A1 Estrogen receptor modulators |
| 05/11/2006 | CA2585334A1 Indole derivatives useful as progesterone receptor modulators |
| 05/10/2006 | EP1655031A1 Use of dienogest in fixed extended cycle hormonal contraceptives |
| 05/10/2006 | EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 05/10/2006 | EP1653980A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 05/10/2006 | EP1653947A1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1265838B9 Novel fatty acid analogous |
| 05/10/2006 | CN1771239A Vitamin d3 lactone derivatives |
| 05/10/2006 | CN1771233A Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome. |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/10/2006 | CN1255386C Substituted fused heterocyclic compounds |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/04/2006 | WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/04/2006 | WO2006046923A1 A method for differentiation of pancreatic stem cells into insulin producing cells |
| 05/04/2006 | WO2006005726A3 Heterocyclic compounds |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094662 Pharmaceutical compositions for sustained drug delivery |
| 05/04/2006 | US20060093667 Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/03/2006 | EP1652913A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651213A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | CN1768065A Thienopyrimidine compound and use of the same |
| 05/03/2006 | CN1254486C Synthesis and expression of recombinant human parathyroxin gene |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037889 Peptide and plurality of linked ligands that together form a water insoluble complex |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037530 Mixture containing silica; blending, granulation |
| 04/27/2006 | WO2006005581A3 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088580 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion |
| 04/27/2006 | US20060088516 Synthetic peptide combinations and methods of producing same |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1649862A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 04/26/2006 | EP1648933A1 Long lasting insulin derivatives and methods thereof |
| 04/26/2006 | EP1648565A1 Medicament comprising plant material from mascagnia eggersiana for treating type 2 diabetes mellitus |
| 04/26/2006 | EP1648483A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/26/2006 | EP1320710B1 Drying method for selectively removing volatile components from wet coatings |
| 04/26/2006 | CN1762456A Medicine for improving female estrogen and immunity |
| 04/26/2006 | CN1253472C Polyglycol-human growth hormone conjugate and its preparation process and medicinal use |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |